The Struggles of India’s Vaccine Giant

Over the weekend, President Trump called off a trip to Pakistan by two of his negotiators for a potential additional round of talks with Tehran, leaving the fate of the cease-fire in limbo. Farnaz Fassihi, who covers Iran for The New York Times, looks at who is in charge of the c ...  Show more

With war, political wrangling and price hikes jockeying for headlines, it’s a rare thing to sit for an hour with a large group of strangers and focus on the small pleasures in life. But that’s what the show “Every Brilliant Thing” is all about. Since 2013, Duncan Macmillan’s audi ...  Show more

It's time to pay attention! We're not supposed to know about the politicization of lockdown policies, vaccine distribution, schools reopening ... and we're not supposed to say anything about any of it, but this is the time to be watching and taking notice more than ever. -- Today ...  Show more

Thejna John is a happy woman. Last year, the relapse of an acute form of blood cancer despite a bone marrow transplant, had made her doctors give up all hope.

In October, came a breakthrough. India approved the CAR T-Cell therapy, a revolutionary treatment for some form ...

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

Les vaccins contre le Covid-19 sont au centre de toutes les attentions. Ils sont l'espoir auquel se raccrochent les gouvernements du monde entier pour sortir de la crise sanitaire qui nous touche depuis un an. Si leur mise au point s'est faite en un temps record, en matière de ...